<DOC>
	<DOCNO>NCT00863421</DOCNO>
	<brief_summary>Only prospective study systematically investigate prevalence sleep disorder breathing patient stable chronic heart failure . Furthermore report incidence rate sleep disorder breathe population . This prospective multi-centre study sleep-disordered breathe 200 patient stable moderate-to-severe chronic heart failure . Eligible patient undergo overnight full-night polysomnography , lung function testing , laboratory measurement , hemodynamic recording . Measurements repeat 6 month interval follow-up period two year irrespective presence absence sleep disorder breathing . The primary outcome variable study prevalence sleep disorder breathe study population . Secondary outcome variable include 2-year incidence rate sleep disorder breathing , quality life measurement , exercise capacity , sleep quality , hemodynamic measurement , laboratory marker neurohumoral activation , systemic inflammation , endothelial function study population .</brief_summary>
	<brief_title>Sleep Disordered Breathing Patients With Chronic Heart Failure</brief_title>
	<detailed_description>Chronic heart failure complex clinical syndrome result structural functional cardiac non-cardiac disorder impairs ability heart respond physiological demand increase cardiac output . Chronic heart failure characterise symptom exertional breathlessness fatigue , sign fluid retention well sign associate underlie cardiac disorder . Patients chronic heart failure suffer reduce quality life significantly high risk morbidity mortality . There cumulate evidence high prevalence sleep breathing disorder patient acute chronic heart failure . Most report , however , suffer important limitation include small sample size , retrospective study design , and/or use pulse-oximetry cardio-respiratory polygraphy screen sleep disorder breathe rather full-night polysomnography . Hence , previous study may underestimate full scale concomitant sleep disorder breathe patient chronic heart failure . Furthermore , best knowledge , report incidence sleep disorder breathe patient chronic heart failure . In context presence sleep disorder breathe patient chronic heart failure important prognostic relevance . Pathophysiological effect sleep apnea include intermittent hypoxia , sympathetic hyperactivity , systemic inflammation , sleep fragmentation . These factor may contribute worsen cardiac function explain reportedly high risk cardiac morbidity mortality patient chronic heart failure concomitant sleep disorder breathing . Accordingly , aim present study three-fold . First , investigate prevalence sleep breathing disorder patient stable moderate-to-severe chronic heart failure use diagnostic gold standard full-night-polysomnography . Second , assess two-year incidence sleep disorder breathe patient chronic heart failure . Third , identify potential risk factor associate presence absence sleep disorder breathe patient chronic heart failure . The latter assess use lung function measurement , hemodynamic parameter , laboratory marker neurohumoral activation , systemic inflammation , endothelial function patient chronic heart failure . For purpose 200 patient stable moderate-to-severe chronic heart failure study 2 year-period . Patients chronic heart failure screen eligibility regular visit 4 independent heart failure outpatients clinic Vienna . Eligible patient undergo full-night-polysomnography , lung function test , non-invasive hemodynamic monitoring , six minute-walking-test , laboratory measurement 6 month interval total 2 year ( 4 visit ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Stable chronic heart failure ( NYHA IIIV ) , define condition diagnose least 6 month prior inclusion maximally tolerate medical therapy without relevant change symptoms medication 8 week prior inclusion absence hospitalization previous 3 month Ejection fraction equal 35 % Age 18 80 year Instable angina pectoris Acute coronary syndrome within last 6 month Cerebrovascular event ( TIA , PRIND , stroke ) within last 12 month Primary pulmonary hypertension ( systolic PAP &gt; 45 mmHg ) Congenital heart failure Primary heart valve disease Regular use benzodiazepine , sedative , opiate derivative Severe renal ( screatinine &gt; 3 mg/dl ) and/or liver disease ( GPT &gt; 3xULN ) Clinically relevant affection central nervous system ( e.g.epilepsy , multiple sclerosis , ... ) Known moderate severe chronic obstructive pulmonary disease ( FEV1/ ( F ) VC &lt; 70 % und FEV1 &lt; 50 % Soll ) restrictive lung disease total lung capacity &lt; 70 % Untreated hormonal disease ( e.g.hypothyreosis , ... . ) Daily alcohol consumption 60g alcohol per day men 30g alcohol per day woman Implantation pacemaker ICD within previous 6 month St.p . aortocoronary bypass surgery lung resection within previous 12 month Women childbearing age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Sleep disorder breathing</keyword>
	<keyword>Prevalence</keyword>
	<keyword>Chronic heart failure</keyword>
	<keyword>Incidence</keyword>
	<keyword>Sleep apnea</keyword>
	<keyword>Cheyne-Stokes-Breathing</keyword>
</DOC>